СТАНДАРТЫ И НЕРЕШЕННЫЕ ВОПРОСЫ В ЛЕЧЕНИИ РАННЕГО РАКА ЯИЧНИКОВ
https://doi.org/10.17650/1994-4098-2009-0-3-4-101-107
Аннотация
Об авторах
Н. Г. КормошРоссия
К. П. Лактионов
Россия
Н. С. Кержковская
Россия
Список литературы
1. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2006 г. Вестн РОНЦ им Н.Н. Блохина РАМН 2008;19(2 прил 1).
2. Omura G.A., Brady M.F., Homesley H.D. et al. Long-term follow- up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experi- ence. J Clin Oncol 1991;9(7):1138—50. 3. Dembo A.J., Davy M., Stenwig A.E. et al. Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990;75(2):263—73.
3. Goff B.A., Mandel L., Drescher C.W. et al. Development of an ovarian cancer symptom index. Cancer 2007;109:221—7.
4. NCCN Practice Guidelines in Oncology 2009. Vol. 1.
5. Ozols R.F., Rubin S.C., Thomas G. et al. Epithelial ovarian cancer. In: Principles and practice of gynecologic oncology. W.J. Hoskins, C.A. Perez, R.C. Young, eds. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 919—22.
6. Grover S., Quinn M.A., Weideman P. et al. Screening for ovarian cancerusing serum CA125 and vaginal examination: report on 2550 females. Int J Gynecol Cancer 1995;5:291—5.
7. Jacobs I.J., Skates S., Davies A.P. et al. Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study. BMJ 1996;313:1355—8.
8. Skates S.J., Menon U., MacDonald N. et al. Calculation of the risk of ovarian can- cer from serial CA-125 values for preclini- cal detection in postmenopausal women. J Clin Oncol 2003;21(10 suppl):206—10.
9. Rosenthal A.N., Menon U., Jacobs I.J. Screening for ovarian cancer. Clin Obstet Gynecol 2006;49:433—47.
10. Jacobs I.J., Skates S.J., MacDonald N. et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 1999;353:1207—10.
11. McBee W.C., Escobar P.F., Falcone T. Which ovarian masses need intervention? Cleveland Clin J Med 2007;74(2):149—77.
12. Rulin M.C., Preston A.L. Adnexal masses in postmenopausal women. Obstet Gynecol 1987;70:578—81.
13. Im S.S., Gordon A.N., Buttin B.M. et al. Validation of referral guidelines for women with pelvic masses. Obstet Gynecol 2005;105:35—41.
14. Kurtz A.B., Tsimikas J.V., Tempany C.M. et al. Diagnosis and stag- ing of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis—report of the Radiology Diagnostic Oncology Group. Radiology 1999;212:19—27.
15. Nam E., Kim Y., Kim J. et al. Diagnosis and staging of ovarian cancer: Comparative
16. values of PET/CT, Doppler US, CT, and MRI correlated with histopathologic analysis. ASCO Annual Meeting Proceedings (Post-Meeting Edition). J Clin Oncol 2008;26(15 Suppl):5567.
17. Young R.C., Decker D.G., Wharton J.T. et al. Staging laparotomy in early ovarian cancer JAMA 1983;250:3072—6.
18. Piver M.S., Marchetti D.L. Potential for cure in ovarian cancer. Compr Ther 1986;12:13—20.
19. Минимальные клинические реко- мендации Европейского общества ме- дицинской онкологии. Под ред. С.А. Тюляндина, Н.И. Переводчико- вой, Д.А. Носова. М.: РОНЦ им.
20. Н.Н. Блохина РАМН, 2007. с. 34—7.
21. Faber A.N., Rose P.G. Роль хирур- гии в лечении рака яичников. J Clin Oncol 2007;1(4):331—41.
22. Zanetta G., Chiari S., Rota S. et al. Conservative surgery for stage I ovarian car- cinoma in women of childbearing age. Br J Obstet Gynaecol 1997;104(9):1030—5.
23. Cliby W.A., Aletti G.D., Wilson T.O., Podratz KC. Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol 2006;12.103:797—801.
24. Burghardt E., Pickel H., Lahousen M., Stettner H. Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol 1986;155:315—9.
25. Maggioni A., Benedetti Panici P, Dell A.T. et al. Randomized study of sys- tematic lymphadenectomy in patients with epithelial ovarian cancer macro- scopically confined to the pelvis. Br J Cancer 2006;95:699—704.
26. Onda T., Yoshikawa H., Yasugi T. et al. Patients with ovarian carcinoma upstaged to stage IIIc after systematic lymphadenec- tomy have similar survival to stage I/II patients and superior survival to other stage III patients. Cancer 1998;83:1555—60.
27. Hacker N.F., Valmadre S., Robertson G. Management of retroperitoneal lymph nodes in advanced ovarian cancer. J Gynecol Cancer 2008;18(Suppl 1):7—10.
28. Ryan M., Stainton C., Slay tor E. et al.Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust NZ Obstet Gynaecol 2003;43:148—51.
29. Krishnan C.S., Grant P.T., Robertson G., Hacker N.F. Lymphatic ascites following lymphadenectomy for gynaecological malignancy. Int J Gynecol Cancer 2001;11:392—6.
30. Ahmed F.Y., Wiltshaw E., Nocol B. et al. Natural history and prognosis of untreated stage I epithelial ovarian carci- noma. J Clin Oncol 1996;14(11):2968—75.
31. Robert C. Young early-stage ovarian cancer: to treat or not to treat. J National Cancer Inst 2003;95(2).
32. Hreshchyshyn M.M., Park R.C., Blessing J.A. et al. The role of adjuvant therapy in stage I ovarian cancer. Am J Obstet Gynecol 1980;138:139—45.
33. Young R.C., Walton L.A., Ellenberg S.S. et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer: results of two prospective randomized trials. N Engl J Med 1990;322:1021—7.
34. Vergote I.B., Vergote-De Vos L.N., Abeler V.M. et. al. Randomized trial comparing cisplatin with radioactive phosphorus or whole abdomen irradia- tion as adjuvant treatment of ovarian can- cer. Cancer 1992;69:741—9.
35. Bolis G., Colombo N., Pecorelli S. et al. G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica. Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). Ann Oncol 1995;6:887—93.
36. Young R.C., Brady M.F., Nieberg R.K. et al. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin — a gynecologic oncology group study. J Clin Oncol 2003;21:4350—5.
37. Trimbos J.B., Parmar M. International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003;95(2):105—12.
38. Trimbos J.B, Vergote I., Bolis G., Vermorken J. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial. J Natl Cancer Inst 2003;95(2):113—25.
39. Vergote I., De Brabander J., Fyles A. et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001;357:176—82.
40. Kolomainen D.F., A’Hern R., Coxon F.Y. et al. Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy? J Clin Oncol 2003;21(16):3113—8.
41. Bell J., Brady M.F., Young R.C. et al. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and pacli- taxel in early stage epithelial ovarian carci- noma: a Gynecologic Oncology Group study. Gynecol Oncol 2006;102(3):432—9.
42. Winter-Roach B.A., Kitchener H.C., Dickinson H.O. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD004706. DOI: 10.1002/14651858.CD004706.pub2.
Рецензия
Для цитирования:
Кормош Н.Г., Лактионов К.П., Кержковская Н.С. СТАНДАРТЫ И НЕРЕШЕННЫЕ ВОПРОСЫ В ЛЕЧЕНИИ РАННЕГО РАКА ЯИЧНИКОВ. Опухоли женской репродуктивной системы. 2009;(3-4):101-107. https://doi.org/10.17650/1994-4098-2009-0-3-4-101-107
For citation:
Kormosh N.G., Laktionov K.P., Kerzhkovskaya N.S. MANAGEMENT IN EARLY OVARIAN CANCER: STANDARDS AND UNSOLVED PROBLEMS. Tumors of female reproductive system. 2009;(3-4):101-107. (In Russ.) https://doi.org/10.17650/1994-4098-2009-0-3-4-101-107